<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During studies of T-cell recognition of autologous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells, a number of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell lines derived from patients with <z:hpo ids='HP_0002665'>lymphoma</z:hpo> proved to be poor stimulators of both autologous and allogeneic T-cell responses </plain></SENT>
<SENT sid="1" pm="."><plain>Analysis of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell surface molecules indicated that expression of the lymphocyte-function-associated antigen, LFA-1, was lacking, whereas <z:mpath ids='MPATH_458'>normal</z:mpath> leucocytes from these patients expressed <z:mpath ids='MPATH_458'>normal</z:mpath> levels of LFA-1 </plain></SENT>
<SENT sid="2" pm="."><plain>Examination of other <z:e sem="disease" ids="C0598798" disease_type="Neoplastic Process" abbrv="">lymphoid tumours</z:e> revealed that most high grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, but not most low or intermediate grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, do not express the LFA-1 molecule </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, in an initial survey, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> from 5 of 7 patients with non-relapsing large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> expressed LFA-1 whereas only 3 of 18 patients with relapsing <z:hpo ids='HP_0002665'>lymphomas</z:hpo> had <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> that did so </plain></SENT>
<SENT sid="4" pm="."><plain>These findings suggest that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells lacking surface LFA-1 cannot initiate an effective immune response in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>This lack of immunogenicity might contribute to escape from immunosurveillance </plain></SENT>
</text></document>